New Graft-Versus-Host Disease Study Findings Recently Were Reported by Researchers at City of Hope National Medical Center (Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With...).

For more information on this research see: Tocilizumab for Cytokine Release Syndrome Management After Haploidentical Hematopoietic Cell Transplantation With Post-transplantation Cyclophosphamide-based Graft-versus-host Disease Prophylaxis. Keywords: Duarte; State:California; United States; North and Central America; Alkylating Agents; Antineoplastics; Biomedicine; Biotechnology; Cell Transplantation; Cell Transplants; Cyclophosphamide; Cyclophosphamide Therapy; Cytokines; Drugs and Therapies; Graft-Versus-Host Disease; Health and Medicine; Hematology; Hematopoietic; Hydrocarbons; Immune System Diseases and Conditions; Immunologic Agents; Immunotherapy; Intercellular Signaling Peptides and Proteins; Monoclonal Antibodies; Mustard Compounds; Organophosphorus Compounds; Pharmaceuticals; Phosphoramide Mustards; Surgery; Tocilizumab Therapy; Transplant Medicine EN Duarte State:California United States North and Central America Alkylating Agents Antineoplastics Biomedicine Biotechnology Cell Transplantation Cell Transplants Cyclophosphamide Cyclophosphamide Therapy Cytokines Drugs and Therapies Graft-Versus-Host Disease Health and Medicine Hematology Hematopoietic Hydrocarbons Immune System Diseases and Conditions Immunologic Agents Immunotherapy Intercellular Signaling Peptides and Proteins Monoclonal Antibodies Mustard Compounds Organophosphorus Compounds Pharmaceuticals Phosphoramide Mustards Surgery Tocilizumab Therapy Transplant Medicine 1251 1251 1 10/16/23 20231017 NES 231017 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Researchers detail new data in Immune System Diseases and Conditions - Graft-Versus-Host Disease. [Extracted from the article]